Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020139843 - ENGINEERED HEPATITIS B CORE POLYPEPTIDE

Publication Number WO/2020/139843
Publication Date 02.07.2020
International Application No. PCT/US2019/068370
International Filing Date 23.12.2019
IPC
C07K 1/113 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
1General processes for the preparation of peptides
107by chemical modification of precursor peptides
113without change of the primary structure
C07K 1/107 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
1General processes for the preparation of peptides
107by chemical modification of precursor peptides
C07K 14/005 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
005from viruses
A61K 9/51 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
48Preparations in capsules, e.g. of gelatin, of chocolate
50Microcapsules
51Nanocapsules
A61K 38/16 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
CPC
C07K 14/005
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
005from viruses
C07K 14/02
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
005from viruses
01DNA viruses
02Hepadnaviridae, e.g. hepatitis B virus
C12N 2730/10122
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
2730Reverse Transcribing DNA Viruses
00011Reverse Transcribing DNA Viruses
10011Hepadnaviridae
10111Orthohepadnavirus, e.g. hepatitis B virus
10122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
C12N 2730/10123
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
2730Reverse Transcribing DNA Viruses
00011Reverse Transcribing DNA Viruses
10011Hepadnaviridae
10111Orthohepadnavirus, e.g. hepatitis B virus
10123Virus like particles [VLP]
C12N 2730/10142
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
2730Reverse Transcribing DNA Viruses
00011Reverse Transcribing DNA Viruses
10011Hepadnaviridae
10111Orthohepadnavirus, e.g. hepatitis B virus
10141Use of virus, viral particle or viral elements as a vector
10142virus or viral particle as vehicle, e.g. encapsulating small organic molecule
C12N 7/00
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
7Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
Applicants
  • THE BOARD OF TRUSTEE OF THE LELAND STANFORD JUNIOR UNIVERSITY [US]/[US]
Inventors
  • SWARTZ, James R.
  • MATHEW, Rinchu
  • ROHOVIE, Marcus John
  • NAGASAWA, Maya
Agents
  • SHERWOOD, Pamela J.
Priority Data
62/785,86628.12.2018US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) ENGINEERED HEPATITIS B CORE POLYPEPTIDE
(FR) POLYPEPTIDE NOYAU DE L'HÉPATITE B GÉNÉTIQUEMENT MODIFIÉ
Abstract
(EN)
Genetically modified HBc polypeptides are provided.
(FR)
L'invention concerne des polypeptides HBc génétiquement modifiés.
Also published as
Latest bibliographic data on file with the International Bureau